# FDA Inspection 829223 - Vitalant - April 22, 2013

Source: https://www.keypedia.com/records/fda_inspections/vitalant/c5effad7-b47c-438b-877b-7dcc748d139d
Source feed: FDA_Inspections

> FDA Inspection 829223 for Vitalant on April 22, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 829223
- Company Name: Vitalant
- Inspection Date: 2013-04-22
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1269826 - 2025-04-29](https://www.keypedia.com/records/fda_inspections/vitalant/22e4f0f8-995c-477d-9142-c0814c016d71)
- [FDA Inspection 1269826 - 2025-04-29](https://www.keypedia.com/records/fda_inspections/vitalant/d4700c75-9493-46fe-97ba-f1526e131d6f)
- [FDA Inspection 1094738 - 2019-06-07](https://www.keypedia.com/records/fda_inspections/vitalant/98bde3eb-ec9a-4aa5-a925-860de860a6ab)
- [FDA Inspection 995059 - 2016-12-20](https://www.keypedia.com/records/fda_inspections/vitalant/1bde550c-4d11-4692-adbb-3b1936e1c6d7)
- [FDA Inspection 925603 - 2015-05-07](https://www.keypedia.com/records/fda_inspections/vitalant/0ab36126-7acb-4027-a00e-fc66b32f7b87)

Company: https://www.keypedia.com/companies/vitalant/295e9328-eb22-4eab-b2d2-ceb994493316

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d